Release of guanylin immunoreactivity from the isolated vascularly perfused rat colon.
The intestinal peptide guanylin regulates the electrolyte/water transport in the intestinal epithelium. The aim of the present study was to investigate the mechanisms that modulate its secretion in the isolated vascularly perfused rat colon by using a specific guanylin RIA. Intraarterial infusion of bethanechol (10(-4) M) or bombesin (10(-7) M) elicited a significant 6-fold increase in the release of guanylin immunoreactivity (G-IR) in the lumen. Bombesin-stimulated G-IR secretion was strongly reduced by tetrodotoxin, whereas atropine had no effect. VIP (10(-7) M) induced a moderate release of G-IR, whereas substance P, calcitonin gene-related peptide, peptide YY, somatostatin, and neurotensin were without effect. Dimethyl-PGE2 (1.4 x 10(-5) M) or interleukin-1beta (2.5 x 10(-10) M) induced a 3-fold increase in G-IR in the lumen, whereas the degranulator compound bromolasalocid did not stimulate guanylin secretion. Forskolin (10(-5) M) or sodium nitroprusside (10(-4)-10(-3) M) induced a significant release of G-IR. In contrast, PMA (10(-7) M) or ionophore A23187 (10(-6) M) did not modify basal secretion of G-IR. Upon stimulation of guanylin release with bombesin or bethanechol, an increase in G-IR in the portal effluent was also detected. The release of G-IR in the portal effluent was 40-fold lower than that of G-IR into the luminal perfusate. Additionally, analysis with gel chromatography revealed that the immunoreactive material released in the lumen or in the portal effluent coeluted with the 15-amino acid peptide originally isolated from rat intestine. In conclusion, the present data suggest that the enteric nervous system and immune cells may modulate guanylin release from the rat colon. The release of guanylin in the lumen and portal effluent suggests that this peptide may exert both luminal/paracrine and hormonal effects.
Moro
F
F
INSERM, U-45, Hôpital Edouard Herriot, Lyon, France.
Levenez
F
F
Nemoz-Gaillard
E
E
Pellissier
S
S
Plaisancie
P
P
Cuber
J C
JC
D000818:Animals; D001808:Blood Vessels / Q000502:physiology; D002850:Chromatography, Gel; D003106:Colon / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism*; D005768:Gastrointestinal Hormones; D066298:In Vitro Techniques; D018836:Inflammation Mediators / Q000494:pharmacology; D008297:Male; D045265:Natriuretic Peptides; D018377:Neurotransmitter Agents / Q000494:pharmacology; D010455:Peptides / Q000378:metabolism*; D010477:Perfusion; D011863:Radioimmunoassay; D051381:Rats; D017208:Rats, Wistar
D005768:Gastrointestinal Hormones; D018836:Inflammation Mediators; D045265:Natriuretic Peptides; D018377:Neurotransmitter Agents; D010455:Peptides; C072685:guanylin